Discover the world of Biib, a brand known for its high-quality products. From electronics to fashion, Biib offers a wide range of innovative and stylish items. Experience exceptional shopping at Ubuy, the official website for Biib in Pakistan.
Biib is a biotechnology company focused on developing medications for the treatment of neurological and neurodegenerative diseases. Their primary focus is on developing treatments for multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy.
Biib was founded in 1978 as Biogen
The company launched its first multiple sclerosis drug, Avonex, in 1996
In 2020, the company announced plans to spin off its hemophilia business into a separate publicly traded company
Novartis is a Swiss multinational pharmaceutical company that develops and produces a wide range of pharmaceuticals including treatments for multiple sclerosis and Alzheimer's disease.
Roche is a Swiss multinational healthcare company that produces a wide range of pharmaceuticals including treatments for multiple sclerosis and Alzheimer's disease.
An injectable medication for the treatment of multiple sclerosis, Avonex is one of the first disease-modifying drugs approved for MS.
An oral medication for the treatment of multiple sclerosis, Tecfidera is one of the most commonly prescribed disease-modifying drugs for MS.
A medication for the treatment of spinal muscular atrophy, Spinraza is the first and only FDA-approved treatment for this rare and debilitating disease.
Biib is focused on developing treatments for neurological and neurodegenerative diseases, with a primary focus on multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy.
Avonex is an injectable medication developed by Biib for the treatment of multiple sclerosis. It is one of the first disease-modifying drugs approved for MS and helps reduce relapses and slow the progression of the disease.
The most common side effect of Tecfidera is flushing or redness of the skin,rarely flushing can also result from low blood pressure, which occurs in less than 1% of patients. Other side effects include stomach problems and decreased white blood cell count.
Spinraza is a medication developed by Biib for the treatment of spinal muscular atrophy. It is the first and only FDA-approved treatment for this rare and debilitating disease and helps halt and improve symptoms of the disease.
Biib's competitors include Novartis and Roche, both of which also produce treatments for multiple sclerosis and Alzheimer's disease. Novartis and Roche have a larger workforce and more diverse product portfolio than Biib.
Express ShippingFast Delivery
Standard Shipping10+ Business Days